Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the Double Marker Test + PLGF-Roche Test is usually 5-7 working days.

What are the prerequisites for the test Double Marker Test + PLGF- Roche Test

  • Confirmation of pregnancy by ultrasound
  • Maternal age over 35 years
  • Previous history of chromosomal abnormalities
  • Family history of genetic disorders
  • Multiple miscarriages or stillbirths
  • Exposure to certain medications or chemicals during pregnancy

What are the measure values for the test Double Marker Test + PLGF- Roche Test

  • AFP: 0.5-2.5 MoM
  • hCG: 0.5-2.5 MoM
  • PAPP-A: 0.5-2.5 MoM
  • Pregnancy-associated plasma protein-A (PAPP-A): 0.5-2.5 MoM

What does this test Double Marker Test + PLGF- Roche Test identify?

The Double Marker Test + PLGF- Roche Test is a diagnostic test that is used to identify certain health conditions in pregnant women. This test combines two separate tests - the Double Marker Test and the PLGF- Roche Test.

The Double Marker Test is a screening test that measures the levels of two hormones - beta-hCG and PAPP-A - in the mother's blood. Abnormal levels of these hormones can indicate a higher risk of chromosomal abnormalities in the fetus, such as Down syndrome.

The PLGF- Roche Test, on the other hand, measures the levels of a protein called PLGF (placental growth factor) in the mother's blood. Abnormal levels of PLGF can indicate a higher risk of developing pre-eclampsia, a serious pregnancy complication characterized by high blood pressure and damage to other organs.

By combining these two tests, healthcare providers can assess the risk of chromosomal abnormalities in the fetus as well as the risk of pre-eclampsia in the mother. This information can help guide further testing or treatment options to ensure the health and well-being of both the mother and the baby.

Why is this test Double Marker Test + PLGF- Roche Test taken?

Double Marker Test + PLGF- Roche Test

Why is this test taken?

The Double Marker Test + PLGF- Roche Test is taken to assess the risk of chromosomal abnormalities in the fetus, such as Down syndrome and trisomy 18. This test is typically recommended for pregnant women who are at an increased risk of having a baby with a genetic disorder.

The Double Marker Test measures the levels of two specific hormones in the mother's blood - hCG (human chorionic gonadotropin) and PAPP-A (pregnancy-associated plasma protein A). Abnormal levels of these hormones can indicate a higher risk of chromosomal abnormalities in the fetus.

The PLGF- Roche Test, on the other hand, measures the levels of placental growth factor (PLGF) in the mother's blood. Low levels of PLGF can be associated with an increased risk of complications such as preeclampsia and fetal growth restriction.

By combining these two tests, healthcare providers can better assess the overall risk to the fetus and provide appropriate counseling and care to the expectant mother.

No FAQs available.

Customer Google Rating